Oxolinic acid, nalidixic acid and 5Nok in the treatment of urinary tract infections.
D004341:Drug Evaluation; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D010093:Oxolinic Acid / Q000627:therapeutic use*; D015125:Oxyquinoline / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D006912:Hydroxyquinolines; D009268:Nalidixic Acid; D015125:Oxyquinoline; D010093:Oxolinic Acid